mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
epigallocatechin-3-monogallate |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
CR-1-31B |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.6 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.6 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |